SCIENTIFIC COMMITTEE AT:

October, 23rd and 24th, 2013, Barcelona

Ann Tsukamoto, Executive Vice President, Scientific & Strategic Alliances of StemCells Inc., Newark, Canada Ann Tsukamoto joined StemCells, Inc. in 1998 as Senior Director, Scientific Operations, to help start the Company's California operations, and has since held several leadership roles at the Company. In June 2013, Tsukamoto was appointed Executive Vice President, Scientific and Strategic Alliances and is responsible for developing the Company's alliances with research institutions, corporations, government agencies, and disease foundations. From September 2008 to June 2013, she served as the Company's Executive Vice President of Research and Development. Under her direction, the Company identified and purified the human neural stem cell and populations of human liver and pancreatic cells with stem cell-like properties, successfully transitioned into clinical translation, and initiated and completed its first human clinical trials. Before joining the Company, Tsukamoto was a co-discoverer of the human hematopoietic stem cell while at SyStemix, Inc., a stem cell and gene therapy company. Tsukamoto received her PhD from the University of California, Los Angeles and did postdoctoral research with Dr. Harold Varmus at the University of California, San Francisco where she worked on the wnt-1 gene, which is a key player in the stem cell self-renewal pathway. Tsukamoto is an inventor on seven issued US patents related to the human hematopoietic stem cell and gene transfer methods.